KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced that Maxine Gowen, Ph.D., its chief executive officer, will present a company overview at the 2015 JMP Securities Life Sciences Conference on Wednesday, June 24, 2015 at 3:30 p.m. EDT in New York.
Help employers find you! Check out all the jobs and post your resume.
